Erythropoietin Suppresses D-galactose-induced Aging of Rats Via the PI3K/Akt/Nrf2-ARE Pathway

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2020 Jan 16

PMID 31938335

Citations 4

Authors

Haiqin Wu

Mengyi Chen

Pu Yan

Qingling Yao

Jiaxin Fan

Zhen Gao

Huqing Wang

Affiliations

Soon will be listed here.

Abstract

EPO (erythropoietin) is a hormone-like substance with a putative role in hematopoietic regulation. Current research suggests that it exerts a neuroprotective effect by enhancing the activity of antioxidant enzymes. Our previous studies in vitro have confirmed that EPO can delay senescence of cultured neurons by activation of nuclear factor-erythroid 2-related factor 2 (Nrf2) and the phosphoinositide-3-kinase (PI3K)/AKT pathway. Thus we set out to further substantiate the mechanism in vivo. A rat model of aging was induced by continuous subcutaneous injection of 5% D-galactose for 6 weeks. Starting at the 7th week, physiological saline or EPO was administered twice daily. LY294002, an inhibitor of the PI3K/AKT pathway, was also given to one of the groups. Improvement of learning and memory abilities were observed in the EPO intervention group. Raised levels of Cu-Zn SOD protein were detected by immunohistochemical staining and Western blot after using EPO, together with increased expression of PI3K/AKT pathway proteins. Concomitantly, there was an increase in expression of Nrf2 mRNA and a decrease in expression of Keap1 mRNA by qRT-PCR. All these effects were not found in the group injected with LY294002. We conclude that EPO can suppress aging by reducing oxidative stress. The proposed mechanism is an upregulation of the PI3K/Akt/Nrf2-ARE pathway and thus maintenance of expression and activation of antioxidant enzymes in aging rats.

Citing Articles

Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway.

Naguib S, DeJulius C, Backstrom J, Haider A, Ang J, Boal A Antioxidants (Basel). 2023; 12(3).

PMID: 36978804 PMC: 10045745. DOI: 10.3390/antiox12030556.

Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection.

Cho B, Yoo S, Kim S, Lee C, Lee Y, Lee S Redox Biol. 2021; 49:102223.

PMID: 34953452 PMC: 8715119. DOI: 10.1016/j.redox.2021.102223.

The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization.

Tothova Z, Semelakova M, Solarova Z, Tomc J, Debeljak N, Solar P Int J Mol Sci. 2021; 22(14).

PMID: 34299300 PMC: 8307237. DOI: 10.3390/ijms22147682.

The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging.

Yu C, Xiao J Oxid Med Cell Longev. 2021; 2021:6635460.

PMID: 34012501 PMC: 8106771. DOI: 10.1155/2021/6635460.

References

Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H . Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol. 2011; 24(4):573-94. DOI: 10.1016/j.bpa.2010.10.005. View

Reddy N, Potteti H, Vegiraju S, Chen H, Tamatam C, Reddy S . PI3K-AKT Signaling via Nrf2 Protects against Hyperoxia-Induced Acute Lung Injury, but Promotes Inflammation Post-Injury Independent of Nrf2 in Mice. PLoS One. 2015; 10(6):e0129676. PMC: 4467869. DOI: 10.1371/journal.pone.0129676. View

Li Y, Yang G, Jin L, Yang H, Chen J, Chai G . Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid β42 in mice. Brain Res. 2015; 1618:159-67. DOI: 10.1016/j.brainres.2015.05.031. View

Bogdarin I . [The role of sex steroid hormones and nerobolyl in regulating fatty and amino acid metabolism]. Biull Eksp Biol Med. 1994; 117(6):602-5. View

Wang H, Fan J, Chen M, Yao Q, Gao Z, Zhang G . rhEPO Enhances Cellular Anti-oxidant Capacity to Protect Long-Term Cultured Aging Primary Nerve Cells. J Mol Neurosci. 2017; 62(3-4):291-303. DOI: 10.1007/s12031-017-0937-6. View

Merelli A, Czornyj L, Lazarowski A . Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy. Curr Pharm Des. 2013; 19(38):6791-801. DOI: 10.2174/1381612811319380011. View

Costa L, Garrick J, Roque P, Pellacani C . Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More. Oxid Med Cell Longev. 2016; 2016:2986796. PMC: 4745323. DOI: 10.1155/2016/2986796. View

Cao G, Zhu J, Zhong Q, Shi C, Dang Y, Han W . Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex. Neuropharmacology. 2012; 67:144-54. PMC: 3582331. DOI: 10.1016/j.neuropharm.2012.10.020. View

Khalil S, Amer H, El Behairy A, Warda M . Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies. J Adv Res. 2016; 7(3):348-58. PMC: 4856826. DOI: 10.1016/j.jare.2016.02.004. View

10.

Vogel J, Gassmann M . Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models. J Physiol. 2011; 589(Pt 6):1259-64. PMC: 3082089. DOI: 10.1113/jphysiol.2010.196147. View

11.

Aydin S, Yanar K, Atukeren P, Dalo E, Sitar M, Uslu E . Comparison of oxidative stress biomarkers in renal tissues of D-galactose induced, naturally aged and young rats. Biogerontology. 2011; 13(3):251-60. DOI: 10.1007/s10522-011-9370-3. View

12.

Selman C, Blount J, Nussey D, Speakman J . Oxidative damage, ageing, and life-history evolution: where now?. Trends Ecol Evol. 2012; 27(10):570-7. DOI: 10.1016/j.tree.2012.06.006. View

13.

Kume T, Suenaga A, Izumi Y, Akaike A . Protective Effect of Dimethyl Fumarate on an Oxidative Stress Model Induced by Sodium Nitroprusside in Mice. Biol Pharm Bull. 2016; 39(6):1055-9. DOI: 10.1248/bpb.b16-00134. View

14.

Johnson J, Johnson D, Kraft A, Calkins M, Jakel R, Vargas M . The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci. 2008; 1147:61-9. PMC: 2605641. DOI: 10.1196/annals.1427.036. View

15.

Li Z, Dong X, Liu H, Chen X, Shi H, Fan Y . Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/Akt. Mol Vis. 2013; 19:1656-66. PMC: 3725964. View

16.

Lazarov O, Hollands C . Hippocampal neurogenesis: Learning to remember. Prog Neurobiol. 2016; 138-140:1-18. PMC: 4828289. DOI: 10.1016/j.pneurobio.2015.12.006. View

17.

Merelli A, Czornyj L, Lazarowski A . Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases. Int J Neurosci. 2014; 125(11):793-7. DOI: 10.3109/00207454.2014.989321. View

18.

Fujio Y, Nguyen T, Wencker D, Kitsis R, Walsh K . Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000; 101(6):660-7. PMC: 3627349. DOI: 10.1161/01.cir.101.6.660. View

19.

Sargin D, El-Kordi A, Agarwal A, Muller M, Wojcik S, Hassouna I . Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biol. 2011; 9:27. PMC: 3120735. DOI: 10.1186/1741-7007-9-27. View

20.

Liochev S . Which Is the Most Significant Cause of Aging?. Antioxidants (Basel). 2016; 4(4):793-810. PMC: 4712935. DOI: 10.3390/antiox4040793. View